Prof Pontiano Kaleebu Professor of Immunovirology* United Kingdom Email Pontiano Jump to: Affiliations Publications Share Affiliations MRC/UVRI and LSHTM Uganda Research Unit Selected Publications Data set for: Contraceptive use, prevalence and incidence of pregnancy and associated factors among women participating in a vaccine preparedness cohort study in Masaka, Uganda, a retrospective secondary analysis Kusemererwa, S; KANSIIME, S; Nakamanya, S; Mbabazi, E; Fox, J; McCormack, S; KALEEBU, P; RUZAGIRA, E; PrEPVacc Study Group,; 2024 London School of Hygiene & Tropical Medicine High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response. Mentzer, AJ; Dilthey, AT; Pollard, M; Gurdasani, D; Karakoc, E; Carstensen, T; Muhwezi, A; Cutland, C; Diarra, A; Da Silva Antunes, R; Paul, S; Smits, G; Wareing, S; Kim, H; Pomilla, C; Chong, AY; Brandt, DY C; Nielsen, R; Neaves, S; Timpson, N; Crinklaw, A; Lindestam Arlehamn, CS; Rautanen, A; Kizito, D; Parks, T; ... Sandhu, MS. 2024 Nature medicine The single-dose Janssen Ad26.COV2.S COVID-19 vaccine elicited robust and persistent anti-spike IgG antibody responses in a 12-month Ugandan cohort. Serwanga, J; Kato, L; Oluka, GK; Ankunda, V; Sembera, J; Baine, C; Kitabye, I; Namuyanja, A; Opio, S; Katende, JS; Ejou, P; COVID-19 Immunoprofiling Team,; KALEEBU, P; 2024 Frontiers in immunology Severe morbidity and hospital-based mortality from Rift Valley fever disease between November 2017 and March 2020 among humans in Uganda. Anywaine, Z; HANSEN, C; Warimwe, GM; Abu-Baker Mustapher, G; Nyakarahuka, L; Balinandi, S; Ario, AR; Lutwama, JJ; ELLIOTT, A; KALEEBU, P; 2024 Virology journal Viruses associated with measles-like illnesses in Uganda. Namuwulya, P; Ashraf, S; Niebel, M; Ssekagiri, A; Tushabe, P; Kakooza, P; Tong, L; Bukenya, H; Jerome, H; Davis, C; Birungi, M; Turyahabwe, I; Mugaga, A; Eliku, JP; Francis, A; Nakabazzi, L; Nsubuga, F; Katushabe, E; Kisakye, A; Ampeire, I; Nanteza, A; KALEEBU, P; Bakamutumaho, B; Nsamba, P; Kazibwe, A; ... THOMSON, EC. 2024 The Journal of infection Perceptions, attitudes, and willingness of healthcare and frontline workers to participate in an Ebola vaccine trial in Uganda. Kimbugwe, G; Vatrinet, R; Mwanga, JA; Kakuru, R; Mpeirwe, D; Logoose, S; Opio, K; Kambale, M; SEELEY, J; Grais, RF; Marquer, C; KALEEBU, P; SSALI, A; 2024 Vaccine HLA-A*23 Is Associated With Lower Odds of Acute Retroviral Syndrome in Human Immunodeficiency Virus Type 1 Infection: A Multicenter Sub-Saharan African Study. Lindquist, L; Kilembe, W; Karita, E; Price, MA; Kamali, A; KALEEBU, P; Tang, J; Allen, S; Hunter, E; Gilmour, J; Rowland-Jones, SL; Sanders, EJ; Hassan, AS; Esbjörnsson, J; Esbjörnsson, J; 2024 Open forum infectious diseases The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies. Ankunda, V; Katende, JS; Oluka, GK; Sembera, J; Baine, C; Odoch, G; Ejou, P; Kato, L; COVID-19 Immunoprofiling Team,; KALEEBU, P; Serwanga, J; 2024 Frontiers in immunology Sustained S-IgG and S-IgA antibodies to Moderna's mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations. Serwanga, J; Ankunda, V; Katende, JS; Baine, C; Oluka, GK; Odoch, G; Nantambi, H; Mugaba, S; Namuyanja, A; Ssali, I; Ejou, P; Kato, L; COVID-19 Immunoprofiling Team,; Musenero, M; KALEEBU, P; 2024 Frontiers in immunology Re-testing as a method of implementing external quality assessment program for COVID-19 real time PCR testing in Uganda. Okek, EJ; Masembe, FJ; Kiconco, J; Kayiwa, J; Amwine, E; Obote, D; Alele, S; Nahabwe, C; Were, J; Bagaya, B; Balinandi, S; Lutwama, J; KALEEBU, P; 2024 PloS one See more information Contact United Kingdom Email Pontiano